Kimberly-Clark Q3 2026 Results: Net Income $1.79 Billion on Revenue of $4.13 Billion
- US stocks
- Earnings
- Consumer Staples
Kimberly-Clark (Nasdaq: KMB) reported third quarter 2026 results for the three months ended 30 Sep 2026, with GAAP revenue of $4.13 billion and GAAP net income of $1.79 billion; it said on 5 Nov 2026. GAAP diluted EPS was $5.37, and adjusted EPS, a company-defined measure that excludes items the company says do not reflect underlying operations, was $1.70.
Key highlights
- Revenue (GAAP): $4.13 billion, down 0.4% YoY and 1.3% QoQ
- Operating income (GAAP): $516.0 million, down 16.9% YoY and 18.5% QoQ
- Net income attributable to the company (GAAP): $1.79 billion, up 302.0% YoY
- Diluted EPS (GAAP): $5.37, up 300.7% YoY
- Adjusted EPS attributable to the company (company-defined): $1.70
Summary
| Particulars | Q3 2026 | Q3 2025 | YoY | Q2 2026 | QoQ |
|---|---|---|---|---|---|
| Revenue | 4,134.0 | 4,150.0 | -0.4% | 4,189.0 | -1.3% |
| 516.0 | 621.0 | -16.9% | 633.0 | -18.5% | |
| Operating margin | 12.48% | 14.96% | -2.48 pp | 15.11% | -2.63 pp |
| 1,793.0 | 446.0 | +302.0% | 345.0 | +419.7% | |
| Net income margin | 43.37% | 10.75% | +32.62 pp | 8.24% | +35.13 pp |
| Diluted EPS ($) | 5.37 | 1.34 | +300.7% | 1.04 | +416.3% |
Figures are in $ million except EPS; YoY compares with Q3 2025 and QoQ with Q2 2026. Q3 2026 is the three months to 30 Sep 2026, from the company's release. Earlier quarters are checked against the company's SEC XBRL filings. GAAP; net income attributable to the company; diluted EPS. Changes and margins computed by Blacklitt.
The table shows GAAP revenue of $4.13 billion, down 0.4% from a year earlier and 1.3% from the second quarter of 2026. Operating income was $516.0 million, down 16.9% year on year. Operating margin was 12.5%, against 15.0% a year earlier, 2.5 percentage points lower.
Net income attributable to the company rose 302.0% from $446.0 million a year earlier, and net income was 43.4% of revenue, against 10.7%. The release says the quarter's $1.4 billion of income from discontinued operations included a pre-tax gain of about $1.4 billion from completing the IFP Transaction.
Adjusted figures exclude one-off items
Adjusted figures are the company's own non-GAAP measures. The release says they exclude items it does not believe reflect its underlying operations. In the quarter these included $55 million of charges for the 2024 Transformation Initiative and $106 million for the Kenvue Acquisition, both in operating profit.
Adjusted operating profit was $677 million, against $683 million a year earlier, which the release gives as down 0.9%. Adjusted EPS attributable to the company was $1.70, against $1.82, down 6.6% per the release. Adjusted EPS from continuing operations was $1.70, up 17.2% from $1.45. The company attributed the adjusted gross margin of 35.5%, down 130 basis points, to unfavorable pricing net of cost inflation and supply chain investments, partly offset by productivity savings.
Segments and cash flow
North America net sales were $2.74 billion, up 0.9%, which the company tied to transactions with the Arbex Joint Venture under supply agreements. Its operating profit was $657.0 million, up 2.7%.
International Personal Care net sales were $1.40 billion, down 2.8%, and operating profit was $144.0 million, down 32.7%. The company said the China social media disruption was about a 16.8% headwind to that segment's operating profit.
For the nine months, cash provided by operations, including discontinued operations, was $2.41 billion, against $1.8 billion a year earlier. Total debt from continuing operations was $6.50 billion at 30 Sep 2026, down from $7.2 billion at 31 Dec 2025.
Outlook reaffirmed for 2026
The company reaffirmed its 2026 outlook. It expects organic sales growth about 100 basis points below its weighted average category growth, which it puts at about 1.7% on a trailing twelve-month basis. The company said this mainly reflects China social media disruption, about 100 basis points at company level.
It expects 2026 adjusted operating profit to grow mid-single digits, adjusted EPS from continuing operations to grow high single digits, and adjusted EPS attributable to the company to decline by a low single digit, all on a constant-currency basis.
Inference
Average diluted shares were 333.7 million in the quarter, against 333.1 million a year earlier, and cash dividends declared rose to $1.28 per share from $1.26. The cash flow statement shows no repurchases of common stock in the nine months to 30 Sep 2026, against $140 million a year earlier.
The release gives no numeric full-year 2026 ranges for revenue or GAAP EPS, and no free cash flow figure.
Filed with the US SEC on . Reference: Original filing (SEC)
Disclaimer:
The information available on this article is provided for education and informational purposes only. It does not constitute or provide financial, investment or trading advice and should not be construed as an endorsement of any specific stock or financial strategy in any form or manner. We do not make any representations or warranties regarding the quality, reliability, or accuracy of the information provided. This website may contain links to third-party content. We are not responsible for the content or accuracy of these external sources and do not endorse or verify the information provided by third parties. We are not liable for any decisions made or actions taken based on the information provided on this website.
Figures are from the company's filings with the US Securities and Exchange Commission and are in US dollars. Investing in US stocks from India is subject to the Liberalised Remittance Scheme, currency risk and taxes in both countries.
